摘要
目的：研究东麦克栓酶治疗老年人急性脑梗塞的疗效．方法：将对７２老年脑梗塞病人分为观察组和对照组，采用随机、单盲对照试验．观察组用东菱克栓酶治疗，对照组进行常规治疗，观察治疗前后临床疗效、ＰＴ、血小板、红细胞压积及副作用．结果：治疗组临床症状改善明显，治愈率为９２．１％，与对照组比较有显著性差异（Ｐ＜０．０１）．治疗组治疗后ＰＴ延长，红细胞压积下降，与治疗前比较存在差异（Ｐ＜０．０５）．治疗前后血小板无明显变化．结论：东菱克栓酶治疗老年脑梗塞效果显著、安全、无明显副作用．
Objective: To discuss the effects of Datroxobin (DF-521) on senile acute cerebral infarction. Methods: 72 patients were divided into 2 groups: control group and observation group with mono-blind and randomized trial. DF-521 was administrated in observation group and routine therapy was taken in control group. Clinical curative effect PT, platelet count, hematocrit and side effects were compared with. Results: The clinical curative effect improved obviously with 92.1% in observation group that had significant difference compared with control group. PT prolonged (p〈0.05) and HT decreased (p〈0.05) after treatment in observation group. There was no obvious difference in platelet count in two groups. Conclusion: DF-521 could be effective and safe without side effect on senile acute cerebral infarction.
出处
《伤残医学杂志》
2000年第2期27-28,共2页
Medical Journal of Trauma and Disability
